ALKS

Alkermes Stock Analysis

AI Rating

Neutral
  • Quality10/10
  • Growth 1/10
  • Value 6/10
Alkermes sales and earnings growth
ALKS Growth
Low
  • Revenue Y/Y -5.25%
  • EPS Y/Y -33.78%
  • FCF Y/Y -4.15%
Alkermes gross and profit margin trends
ALKS Profitability
Good
  • Gross margin 86.70%
  • EPS margin 16.40%
  • ROIC 5Y 21.39%
Alkermes net debt vs free cash flow
ALKS Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage 24.7

Alkermes stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗